TrialBritish journal of haematology2023

The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial.

Matthew W Jenner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.